Attachment 2_Track Changes Appendix E-BPHC- UDS- 0915 0193- 3.20.24

UDS Support Center, 866-UDS-HELP, [email protected], BPHC Contact Form

INTRODUCTION

Appendix E: Other Data Elements

The questions on the Other Data Elements Form collect information on the changing landscape of health centers to include expanded services and delivery systems.

Several notable changes have been made to the Other Data Elements Form, as outlined below:

• Medication assisted treatment (MAT) is now referred to as medications for opioid use disorder (MOUD).

• The Drug Addiction Treatment Act of 2000 (DATA) waiver is no longer required to treat opioid use disorder with medications specifically approved by the U.S. Food and Drug Administration (FDA) (i.e., buprenorphine).

QUESTIONS

Report on these data elements as part of your UDS submission. Topics include medications for opioid use disorder (MOUD), telehealth, and outreach and enrollment assistance. Respond to each question based on your health center status as of December 31, 2023.

1. Medications for Opioid Use Disorder (MOUD)

   1. How many providers, on-site or with whom the health center has contracts, treat opioid use disorder with medications specifically approved by the U.S. Food and Drug Administration (FDA) (i.e., buprenorphine) for that indication during the calendar year?

   2. During the calendar year, how many patients received MOUD for opioid use disorder from a provider accounted for in Question 1a?

2. Did your organization use telemedicine to provide remote (virtual) clinical care services?

Note: Telemedicine services refers to remote clinical services with patients.

1. Yes

If “Yes” is selected, proceed to questions 2a1–2a3.

2a1. Who did you use telemedicine to communicate with? (Select all that apply.)

1. Patients at remote locations from your organization (e.g., home telehealth, satellite locations)

2. Specialists outside your organization (e.g., specialists at referral centers) 2a2. What telehealth technologies did you use? (Select all that apply.)

1. Real-time telehealth (e.g., live videoconferencing)

2. Store-and-forward telehealth (e.g., secure e-mail with photos or videos of patient examinations)

3. Remote patient monitoring

4. Mobile Health (mHealth)

2a3. What primary telemedicine services were used at your organization? (Select all that apply.)

1. Primary care

2. Oral health

3. Behavioral health: Mental health

4. Behavioral health: Substance use disorder

5. Dermatology

6. Chronic conditions

7. Disaster management

8. Consumer health education

9. Provider-to-provider consultation

10. Radiology

11. Nutrition and dietary counseling

12. Other (Please describe )

2. No.

If you did not have telemedicine services, please comment on why. (Select all that apply.)

1. Have not considered/unfamiliar with telehealth service options

2. Policy barriers (Select all that apply.)

   1. Lack of or limited reimbursement

   2. Credentialing, licensing, or privileging

   3. Privacy and security

   4. Other (Please describe )

3. Inadequate broadband/telecommunication service (Select all that apply.)

   1. Cost of service

   2. Lack of infrastructure

   3. Other (Please describe )

4. Lack of funding for telehealth equipment

5. Lack of training for telehealth services

6. Not needed

7. Other (Please describe )

3. Provide the number of all assists provided during the past year by all trained assisters (e.g., certified application counselor or equivalent) working on behalf of the health center (personnel, contracted personnel, or volunteers), regardless of the funding source that is supporting the assisters’ activities. Outreach and enrollment assists are defined as customizable education sessions about third-party primary care health insurance coverage options (one-on-one or small group) and any other assistance provided by a health center assister to facilitate enrollment.

Enter number of assists

Note: Assists DO NOT count as visits on the UDS tables.

4. How many health center patients were screened for family planning needs, including contraceptive methods, using a standardized screener during the calendar year?

2

2024 UDS MANUAL | Appendix E